In the context of prostate cancer, the modulation of lactate levels alongside the inhibition of PD-1-mediated immunosuppression in macrophages plays a crucial role in regulating the proliferation of prostate cancer cells that are deficient in PTEN and p53. Here, TP53 is linked to prostate carcinoma.